Artificial intelligence in drug discovery: combining clinical and genomic data from cancer patients to identify genetic biomarkers and potential novel targets

Drug discovery is a costly process affected by a high attrition rate. The huge investment from pharma industry in past years has generated a vast wealth of information in the field that constitutes a great opportunity if it is conveniently exploited. Topazium is a company fully committed to creating a new collective intelligence that enables…